TITLE

Antibiotic allergy in cystic fibrosis

AUTHOR(S)
Parmar, J. S.; Nasser, S.
PUB. DATE
June 2005
SOURCE
Thorax;Jun2005, Vol. 60 Issue 6, p517
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Allergic reactions to antibiotics are more common in cystic fibrosis (CF) than in the general population. This in part is due to the improving survival in adults with CF and the increased use of high, dose intravenous antibiotics. While some are immediate anaphylaxis type (IgE mediated) reactions, the majority are late onset and may have non- specific features such as rash and fever. Piperacillin has consistently been found to have the highest rate of reported reactions (30-50%). There is a low risk of cross reactions between penicillins and other non-β-lactam dasses of antibiotics in penicillin skin prick positive patients. Carbapenems should only be used with extreme caution in patients with positive skin prick tests to penicillin. However, aztreonarn can be used safely in patients who are penicillin allergic with positive skin prick reactions. The aminoglycosides are a relatively uncommon cause of allergic reactions, but patients who react to one member of the family may cross react with other aminoglycosides. Desensitisation relies on the incremental introduction of small quantities of the allergen and has been used for penicillins, ceftazidime, tobramycin and ciprofloxacin and must be repeated before each course. Personalised cards should be regularly updated for patients who develop allergic reactions. Written instructions on the emergency treatment of allergic reactions should be provided to patients self-administering intravenous antibiotics at home. Further research is required to identify risk factors and predictors for antibiotic allergy.
ACCESSION #
17359844

 

Related Articles

  • Minocycline in the Antibiotic Regimen of Cystic Fibrosis Patients: Weight Gain and Clinical Improvement. Patterson, Paul R. // Clinical Pediatrics;Jan1977, Vol. 16 Issue 1, p60 

    Minocycline hydrochloride was given to 100 patients with cystic fibrosis of the pancreas for periods of 3 months over a broad-spectrum antibiotic drug rotation which lasted 2 years. Increased weight gain and some clinical improvement was seen during treatment with minocycline. Those patients...

  • Cystic fibrosis: clinical aspects.  // Thorax;Dec2004 Supplement, Vol. 59, p78 

    The article presents some papers related to clinical aspects of cystic fibrosis (CF). People with CF are at an increased risk of acquiring candidiasis. The study determines the prevalence of symptomatic candidiasis, the risk factors for infection, and the association between treatments received...

  • Simultaneous overexpression of multidrug efflux pumps in Pseudomonas aeruginosa non-cystic fibrosis clinical isolates. Poonsuk, Kanchana; Tribuddharat, Chanwit; Chuanchuen, Rungtip // Canadian Journal of Microbiology;Jul2014, Vol. 60 Issue 7, p437 

    The purpose of this study was to examine expression and regulation of 6 multidrug efflux systems, including MexAB-OprM, MexCD-OprJ, MexEF-OprN, MexXY, MexJK, and MexVW, in 13 non-cystic fibrosis (CF) clinical isolates of Pseudomonas aeruginosa. These isolates displayed a high level of resistance...

  • Management of Patients with Cephalosporin Allergy. Zepf, Bill // American Family Physician;3/15/2002, Vol. 65 Issue 6, p1196 

    Presents information on a review by P.S. Kelkar and J.T. Li of cephalosporin allergy with suggestions for clinical management. Description of the review and its results; Recommendation for avoiding the use of cephalosporin antibiotics in patients with a history of penicillin allergy when...

  • Long term clinical outcome of home and hospital intravenous antibiotic treatment in adults with cystic fibrosis. Thornton J; Elliott R; Tully M P; Dodd M; Webb A K // Thorax;Mar2004, Vol. 59 Issue 3, p242 

    BACKGROUND: Several studies have suggested that clinical outcomes in adults with cystic fibrosis (CF) are equivalent after home and hospital treatment with intravenous antibiotics, but these studies were small and selective and only considered one course of treatment. METHODS: A retrospective...

  • End-of-Life Care in Adults with Cystic Fibrosis. Philip, Jennifer A.M.; Gold, Michelle; Sutherland, Sharon; Finlayson, Felicity; Ware, Claire; Braithwaite, Maxine; Harris, Jane; Kotsimbos, Tom; Wilson, John F. // Journal of Palliative Medicine;Mar2008, Vol. 11 Issue 2, p198 

    Background: Cystic fibrosis (CF) is a life-limiting congenital disease, with most patients dying at a young age of progressive lung disease. Lung transplantation offers hope for many but may not occur. There is little to guide the provision of palliative care to this young population who...

  • Treatment of Aspergillus fumigatus in Patients with Cystic Fibrosis: A Randomized, Placebo-Controlled Pilot Study. Aaron, Shawn D.; Vandemheen, Katherine L.; Freitag, Andreas; Pedder, Linda; Cameron, William; Lavoie, Annick; Paterson, Nigel; Wilcox, Pearce; Rabin, Harvey; Tullis, Elizabeth; Morrison, Nancy; Ratjen, Felix // PLoS ONE;Apr2012, Vol. 7 Issue 4, p1 

    Background: Many patients with cystic fibrosis develop persistent airway infection/colonization with Aspergillus fumigatus, however the impact of A. fumigatus on clinical outcomes remains unclear. The objective of this study was to determine whether treatment directed against Aspergillus...

  • Evaluation of the Merlin, Micronaut System for Automated Antimicrobial Susceptibility Testing of Pseudomonas aeruginosa and Burkholderia Species Isolated from Cystic Fibrosis Patients. Häussler, S.; Ziesing, S.; Rademacher, G.; Hoy, L.; Weiβbrodt, H. // European Journal of Clinical Microbiology & Infectious Diseases;Aug2003, Vol. 22 Issue 8, p496 

    Since accurate antimicrobial susceptibility testing of bacterial cystic fibrosis isolates is known to be problematic and an optimal in vitro testing method has not yet been evaluated, the study presented here was conducted to compare the performance of the reference agar dilution method and...

  • Genetic relatedness and host specificity of Pseudomonas aeruginosa isolates from cystic fibrosis and non-cystic fibrosis patients. AbdulWahab, Atqah; Taj-Aldeen, Saad J.; Ibrahim, Emad; Abdulla, Shaikha H.; Muhammed, Ramees; Ahmed, Irshad; Abdeen, Yasmine; Sadek, Omnia; Abu-Madi, Marawan // Infection & Drug Resistance;2014, Vol. 7, p309 

    Background: Pseudomonas aeruginosa is one of the primary pathogens isolated more frequently in cystic fibrosis (CF) and it exhibits innate resistance to a wide range of antibiotics. Purpose: We sought to determine whether the highly prevalent genotypes of P. aeruginosa are specifically linked to...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics